How Lobo was paid
$21.4M in total for 2025, as reported in the Summary Compensation Table. Equity awards are valued at grant, not at what they turned out to be worth.
Named executive officers
| Executive | Salary | Stock | Options | Incentive | Other | Total |
|---|---|---|---|---|---|---|
| Kevin A. LoboChair, Chief Executive Officer and President | $1,491,667 | $9,764,136 | $6,920,781 | $2,250,000 | $974,911 | $21,401,495 |
| Preston W. WellsVice President, Chief Financial Officer | $653,431 | $1,841,377 | $1,297,717 | $514,558 | $103,339 | $4,410,422 |
| Spencer S. StilesGroup President, Orthopaedics | $792,500 | $2,685,078 | $1,903,300 | $760,000 | $188,081 | $6,328,959 |
| J. Andrew PierceGroup President, MedSurg and Neurotechnology | $792,500 | $2,685,078 | $1,903,300 | $754,148 | $188,081 | $6,323,107 |
| Viju S. MenonGroup President, Global Quality and Operations | $675,000 | $1,647,444 | $1,167,889 | $578,000 | $167,476 | $4,235,809 |
| Glenn S. BoehnleinAdvisor to the Chief Executive Officer and Former Vice President, Chief Financial Officer | $800,000 | — | — | $800,000 | $293,046 | $1,893,046 |
What changed and why
- $21.4MChief executive officer total compensation decreased to $21,401,495 in 2025 compared to $21,979,369 in 2024.
- $25,116MNet sales increased 11.2% to $25,116 million for the fiscal year ended December 31, 2025.
- 87%Variable performance and stock-based compensation averaged 87% of total direct compensation for named executive officers in 2025.
- 92%Advisory vote on executive compensation received approximately 92% favorable support at the prior annual meeting.
About this page
Figures are automated and can be wrong; check the filing for the exact numbers. Totals follow SEC rules, which value stock and option awards at grant. Read the DEF 14A proxy statement for footnotes and the compensation committee's full reasoning.